Cholesterol metabolism regulated by CAMKK2-CREB signaling promotes castration-resistant prostate cancer
Cell Reports · 2025-06 · 44 (6) · 115792
DOI: 10.1016/j.celrep.2025.115792 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025-06. Verfasst von Chenchu Lin und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA; UTHealth Graduate School of Biomedic…. Hauptthemen laut MEDLINE: Cyclic AMP Response Element-Binding Protein, Prostatic Neoplasms, Castration-Resistant, Calcium-Calmodulin-Dependent Protein Kinase Kinase, Signal Transduction. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, NLM NIH HHS, Cancer Prevention and Research Institute of Texas.
Abstract (Originalsprache)
Castration-resistant prostate cancer (CRPC) remains an incurable disease in need of improved treatments. CAMKK2 is an emerging therapeutic target whose oncogenic effects in prostate cancer have, to date, been largely attributed to its activation of AMP-activated protein kinase (AMPK). Here, we demonstrate that CAMKK2 promotes prostate cancer growth through an alternative downstream pathway involving CAMKI and CREB. Unbiased transcriptomics identify CREB-mediated transcription as a CAMKK2-regulated process, findings that we validate using diverse molecular, genetic, and pharmacological approaches in vitro and in vivo. CAMKK2 promotes CREB phosphorylation/activation through CAMKIα independently of AMPK, CAMKIV, or other CAMKI isoforms. Functionally, the CREB family members CREB1 and ATF1 exhibit close redundancy, necessitating co-targeting for optimal anti-tumor efficacy. An inhibitor of CREB1/ATF1 blocks CRPC with minimal side effects. Mechanistically, CAMKK2 and CREB increase CRPC growth through augmenting cholesterol metabolism. Together, these findings identify an oncogenic pathway that could be exploited for the treatment of CRPC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA; UTHealth Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center Houston…
- Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.
- Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- Department of Surgery, Baylor College of Medicine, Houston, TX 77030, USA.
- Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA; Mayo Clinic Alix School of Medicine, Phoenix, AZ 85054, USA.
- Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA; McKetta Department of Chemical Engineering, University of Texas at Austin, Austin, TX 78712, USA.
Förderung
- NCI NIH HHS
- NLM NIH HHS
- Cancer Prevention and Research Institute of Texas
- National Institutes of Health National Cancer Institute
- National Library of Medicine
- The University of Texas MD Anderson Cancer Center
- National Institutes of Health
- University of Texas Health Science Center at Houston
Zitieren
APA
Lin, C., Pulliam, T. L., Han, J. J., Xu, J., Recio, C. V., Wilkenfeld, S. R., Shi, Y., Kushwaha, M., Bench, S., Ruiz, E., Senthilkumar, S., Dileep, J., Shepherd, P. D. A., Navone, N. M., Klekers, A. R., Whitley, E. M., Ittmann, M. M., Eberlin, L. S., Wang, W., & Frigo, D. E. (2025). Cholesterol metabolism regulated by CAMKK2-CREB signaling promotes castration-resistant prostate cancer. Cell Reports, 44(6), 115792. https://doi.org/10.1016/j.celrep.2025.115792
Vancouver
Lin C, Pulliam TL, Han JJ, Xu J, Recio CV, Wilkenfeld SR, et al. Cholesterol metabolism regulated by CAMKK2-CREB signaling promotes castration-resistant prostate cancer. Cell Reports. 2025;44(6):115792. doi:10.1016/j.celrep.2025.115792
BibTeX
@article{Lin2025,
author = {Lin, Chenchu and Pulliam, Thomas L and Han, Jenny J and Xu, Jiaqian and Recio, Carlos Vera and Wilkenfeld, Sandi R and Shi, Yan and Kushwaha, Manoj and Bench, Sarah and Ruiz, Eduardo and Senthilkumar, Sanjanaa and Dileep, Jayasurya and Shepherd, Peter D A and Navone, Nora M and Klekers, Albert R and Whitley, Elizabeth M and Ittmann, Michael M and Eberlin, Livia S and Wang, Wenyi and Frigo, Daniel E},
title = {Cholesterol metabolism regulated by CAMKK2-CREB signaling promotes castration-resistant prostate cancer},
journal = {Cell Reports},
year = {2025},
volume = {44},
number = {6},
pages = {115792},
doi = {10.1016/j.celrep.2025.115792}
}
EUVIMED